| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NLTX | Neoleukin Therapeutics, Inc. | BAKER JULIAN | Director | Aug 17, 2023 | Buy | $0.69 | 166,942 | 115,617 | 5,612,949 | Aug 17, 2023, 05:08 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | BAKER JULIAN | Director | Aug 15, 2023 | Buy | $0.63 | 1,888,800 | 1,191,616 | 5,246,614 | Aug 17, 2023, 05:08 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Baker Bros. Advisors (GP) LLC | Director | Aug 16, 2023 | Buy | $0.68 | 229,600 | 156,254 | 5,458,724 | Aug 17, 2023, 05:08 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Smith Sean Michael | Interim CFO, Prin Acct Off | Aug 11, 2023 | Sale | $0.62 | 1,323 | 818 | 21,637 | Aug 14, 2023, 04:06 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Patel Priti | Former Chief Medical Officer | Apr 03, 2023 | Sale | $0.69 | 3,769 | 2,608 | 37,313 | Apr 04, 2023, 08:51 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Smith Sean Michael | Principal Accounting Officer | Feb 02, 2023 | Sale | $0.60 | 3,316 | 1,980 | 15,960 | Feb 03, 2023, 04:33 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Patel Priti | Chief Medical Officer | Feb 02, 2023 | Sale | $0.60 | 14,380 | 8,588 | 31,082 | Feb 03, 2023, 04:32 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Smith Sean Michael | Principal Accounting Officer | Aug 10, 2022 | Sale | $0.99 | 1,655 | 1,641 | 6,776 | Aug 12, 2022, 05:24 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Patel Priti | Chief Medical Officer | May 02, 2022 | Sale | $1.22 | 5,538 | 6,749 | 6,462 | May 03, 2022, 07:16 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | DRACHMAN JONATHAN G | President and CEO | Aug 24, 2021 | Buy | $6.11 | 100,000 | 611,100 | 2,348,686 | Aug 26, 2021, 07:08 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | DRACHMAN JONATHAN G | President and CEO | Aug 25, 2021 | Buy | $6.45 | 50,000 | 322,450 | 25,000 | Aug 26, 2021, 07:08 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Jun 16, 2021 | Sale | $10.19 | 600 | 6,114 | 1,352,489 | Jun 17, 2021, 09:46 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Jun 08, 2021 | Sale | $11.00 | 600 | 6,600 | 1,353,739 | Jun 09, 2021, 05:22 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | May 26, 2021 | Sale | $10.00 | 600 | 6,000 | 1,354,939 | May 26, 2021, 07:37 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | May 19, 2021 | Sale | $10.63 | 600 | 6,378 | 1,355,539 | May 21, 2021, 05:24 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Apr 26, 2021 | Sale | $13.00 | 600 | 7,800 | 1,359,562 | Apr 27, 2021, 07:59 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Apr 21, 2021 | Sale | $11.98 | 1,800 | 21,564 | 1,360,162 | Apr 22, 2021, 05:11 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Apr 14, 2021 | Sale | $12.22 | 1,800 | 21,996 | 1,361,962 | Apr 16, 2021, 07:08 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Apr 07, 2021 | Sale | $12.02 | 1,800 | 21,636 | 1,363,762 | Apr 08, 2021, 07:06 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Mar 31, 2021 | Sale | $11.96 | 1,800 | 21,528 | 1,366,162 | Apr 02, 2021, 05:21 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Mar 22, 2021 | Sale | $12.00 | 600 | 7,200 | 1,369,762 | Mar 24, 2021, 06:48 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Mar 24, 2021 | Sale | $11.95 | 1,800 | 21,516 | 1,367,962 | Mar 24, 2021, 06:48 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Mar 17, 2021 | Sale | $11.36 | 1,200 | 13,632 | 1,370,362 | Mar 18, 2021, 08:45 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Ho Robert | Chief Financial Officer | Mar 17, 2021 | Sale | $11.01 | 6,497 | 71,556 | 21,503 | Mar 18, 2021, 08:44 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Mar 10, 2021 | Sale | $11.97 | 1,800 | 21,540 | 1,371,562 | Mar 11, 2021, 04:14 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Mar 03, 2021 | Sale | $11.87 | 1,800 | 21,360 | 1,373,362 | Mar 04, 2021, 06:52 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Feb 24, 2021 | Sale | $12.14 | 1,800 | 21,852 | 1,375,762 | Feb 25, 2021, 08:17 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Feb 25, 2021 | Sale | $13.00 | 600 | 7,800 | 1,375,162 | Feb 25, 2021, 08:17 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Feb 17, 2021 | Sale | $12.70 | 2,400 | 30,480 | 1,377,562 | Feb 18, 2021, 04:20 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Feb 10, 2021 | Sale | $14.20 | 3,000 | 42,600 | 1,379,962 | Feb 12, 2021, 04:23 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Feb 05, 2021 | Sale | $14.00 | 600 | 8,400 | 1,382,962 | Feb 09, 2021, 04:41 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Walkey Carl | Senior Vice President | Feb 03, 2021 | Sale | $13.23 | 2,400 | 31,752 | 1,383,562 | Feb 05, 2021, 04:51 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | BAKER JULIAN | Director | Jul 07, 2020 | Buy | $15.25 | 424,000 | 6,466,000 | 3,501,691 | Dec 23, 2020, 07:31 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Mar 27, 2020 | Buy | $9.21 | 50,000 | 460,395 | 3,916,579 | Apr 06, 2020, 07:04 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Mar 30, 2020 | Buy | $9.94 | 32,500 | 322,910 | 3,949,079 | Apr 06, 2020, 07:04 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Mar 31, 2020 | Buy | $10.31 | 30,000 | 309,389 | 3,979,079 | Apr 06, 2020, 07:04 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Apr 01, 2020 | Sale | $11.09 | 52,334 | 580,570 | 4,021,579 | Apr 06, 2020, 07:04 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | Green Jeremy | 10% Owner | Apr 02, 2020 | Sale | $11.36 | 49,134 | 558,172 | 4,051,045 | Apr 06, 2020, 07:04 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | DRACHMAN JONATHAN G | President and CEO | Dec 20, 2019 | Buy | $8.40 | 119,047 | 999,995 | 2,198,686 | Dec 20, 2019, 06:53 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | BAKER FELIX | Director | Dec 20, 2019 | Buy | $8.40 | 3,017,542 | 25,347,352 | 12,872,664 | Dec 20, 2019, 05:16 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | DRACHMAN JONATHAN G | See Remarks | Sep 09, 2019 | Buy | $2.85 | 76,822 | 218,559 | 411,250 | Sep 11, 2019, 05:39 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | DRACHMAN JONATHAN G | See Remarks | Sep 10, 2019 | Buy | $3.08 | 36,742 | 113,290 | 447,992 | Sep 11, 2019, 05:39 PM | |
| NLTX | Neoleukin Therapeutics, Inc. | DRACHMAN JONATHAN G | See Remarks | Sep 11, 2019 | Buy | $3.30 | 136,436 | 449,898 | 584,428 | Sep 11, 2019, 05:39 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Baker Bros. Advisors (GP) LLC | Director | Aug 07, 2019 | Buy | $3.05 | 289,725 | 882,884 | 10,105,159 | Aug 08, 2019, 05:00 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Baker Bros. Advisors (GP) LLC | Director | Aug 06, 2019 | Buy | $2.85 | 81,800 | 232,731 | 9,839,472 | Aug 08, 2019, 05:00 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | LEVITT DANIEL J | Director | May 14, 2018 | Sale | $11.62 | 7,812 | 90,736 | 3,906 | May 16, 2018, 07:45 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | MacKenzie Lloyd | Chief Operating Officer | Mar 15, 2018 | Sale | $12.60 | 2,604 | 32,798 | 1,302 | Mar 19, 2018, 05:58 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Main David | President and CEO | Jun 05, 2017 | Sale | $11.38 | 7,250 | 82,496 | 75,155 | Jun 05, 2017, 07:00 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Main David | President and CEO | Jun 01, 2017 | Sale | $11.30 | 12,000 | 135,588 | 77,530 | Jun 05, 2017, 07:00 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Main David | President and CEO | Jun 02, 2017 | Sale | $11.60 | 12,000 | 139,160 | 77,530 | Jun 05, 2017, 07:00 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER FELIX | 10% Owner | Jan 09, 2017 | Buy | $17.18 | 398,062 | 6,836,813 | 9,764,459 | Jan 09, 2017, 06:46 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Baker Bros. Advisors (GP) LLC | 10% Owner | Sep 20, 2016 | Buy | $12.25 | 2,783,605 | 34,110,452 | 9,404,467 | Sep 21, 2016, 04:28 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Baker Bros. Advisors (GP) LLC | 10% Owner | Mar 15, 2016 | Buy | $7.98 | 106,538 | 850,484 | 6,601,891 | Mar 16, 2016, 06:56 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER FELIX | 10% Owner | Mar 16, 2016 | Buy | $8.00 | 361,755 | 2,893,570 | 6,928,119 | Mar 16, 2016, 06:56 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER JULIAN | 10% Owner | Mar 15, 2016 | Buy | $7.88 | 3,374 | 26,582 | 781,421 | Mar 16, 2016, 06:56 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER JULIAN | 10% Owner | Jan 22, 2016 | Buy | $10.78 | 1,887 | 20,345 | 765,980 | Jan 26, 2016, 06:53 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER FELIX | 10% Owner | Jan 22, 2016 | Buy | $10.72 | 50,315 | 539,465 | 6,422,989 | Jan 26, 2016, 06:53 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Baker Bros. Advisors (GP) LLC | 10% Owner | Jan 25, 2016 | Buy | $11.11 | 10,945 | 121,576 | 6,432,847 | Jan 26, 2016, 06:53 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER FELIX | 10% Owner | Jan 26, 2016 | Buy | $10.81 | 77,639 | 839,524 | 6,502,773 | Jan 26, 2016, 06:53 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER FELIX | 10% Owner | Jan 19, 2016 | Buy | $9.08 | 5,029 | 45,642 | 750,354 | Jan 20, 2016, 07:12 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER FELIX | 10% Owner | Jan 19, 2016 | Buy | $9.11 | 73,016 | 665,474 | 6,274,969 | Jan 20, 2016, 07:12 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER FELIX | 10% Owner | Jan 20, 2016 | Buy | $9.48 | 112,034 | 1,062,538 | 6,375,941 | Jan 20, 2016, 07:12 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER FELIX | 10% Owner | Jan 14, 2016 | Buy | $8.17 | 9,970 | 81,472 | 735,198 | Jan 15, 2016, 05:37 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER FELIX | 10% Owner | Jan 14, 2016 | Buy | $8.13 | 107,983 | 878,410 | 6,128,358 | Jan 15, 2016, 05:37 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER FELIX | 10% Owner | Jan 15, 2016 | Buy | $8.47 | 84,670 | 717,201 | 6,204,630 | Jan 15, 2016, 05:37 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Baker Bros. Advisors (GP) LLC | 10% Owner | Jan 14, 2016 | Buy | $8.13 | 107,983 | 878,410 | 6,128,358 | Jan 15, 2016, 05:13 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER FELIX | 10% Owner | Jan 15, 2016 | Buy | $8.47 | 84,670 | 717,201 | 6,204,630 | Jan 15, 2016, 05:13 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER JULIAN | 10% Owner | Jan 14, 2016 | Buy | $8.17 | 9,970 | 81,472 | 735,198 | Jan 15, 2016, 05:13 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | BAKER JULIAN | 10% Owner | Sep 10, 2015 | Buy | $15.50 | 266,563 | 4,131,727 | 725,228 | Sep 11, 2015, 04:11 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Baker Bros. Advisors (GP) LLC | 10% Owner | Sep 10, 2015 | Buy | $15.50 | 2,213,469 | 34,308,770 | 6,022,104 | Sep 11, 2015, 04:11 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Mitchell David Chilton | VP Global Regulatory & Quality | Aug 24, 2015 | Buy | $17.81 | 3,575 | 63,671 | 3,575 | Aug 26, 2015, 04:48 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | MacKenzie Lloyd | VP Technical Operations | Aug 12, 2015 | Option Exercise | $12.22 | 71,774 | 876,719 | 35,887 | Aug 14, 2015, 08:39 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Alam Kamran | CFO, Vice President Finance | Aug 12, 2015 | Sale | $12.22 | 58,158 | 710,400 | 29,079 | Aug 14, 2015, 08:36 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Mitchell David Chilton | VP Global Regulatory & Quality | Aug 11, 2015 | Buy | $24.36 | 1,600 | 38,976 | 1,600 | Aug 13, 2015, 08:20 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | PFIZER INC | 10% Owner | Aug 10, 2015 | Sale | $26.47 | 259,927 | 6,880,295 | 1,235,312 | Aug 12, 2015, 04:30 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | Aug 10, 2015 | Sale | $31.66 | 231,455 | 7,327,865 | 1,383,366 | Aug 12, 2015, 12:24 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | Aug 11, 2015 | Sale | $20.74 | 1,283,366 | 26,617,011 | 100,000 | Aug 12, 2015, 12:24 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON | 10% Owner | Mar 12, 2014 | Buy | $11.00 | 272,727 | 2,999,997 | 1,664,821 | Feb 03, 2015, 12:05 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON | 10% Owner | Dec 16, 2014 | Sale | $7.63 | 6,507 | 49,648 | 1,343,687 | Dec 18, 2014, 10:43 AM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON | 10% Owner | Dec 17, 2014 | Sale | $7.58 | 1,593 | 12,075 | 1,342,094 | Dec 18, 2014, 10:43 AM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON | 10% Owner | Dec 11, 2014 | Sale | $7.50 | 1,355 | 10,163 | 1,353,839 | Dec 15, 2014, 08:48 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON | 10% Owner | Dec 12, 2014 | Sale | $7.51 | 3,645 | 27,374 | 1,350,194 | Dec 15, 2014, 08:48 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON | 10% Owner | Dec 08, 2014 | Sale | $7.69 | 2,000 | 15,380 | 1,361,494 | Dec 10, 2014, 09:13 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON | 10% Owner | Dec 09, 2014 | Sale | $7.73 | 5,000 | 38,650 | 1,356,494 | Dec 10, 2014, 09:13 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON | 10% Owner | Dec 10, 2014 | Sale | $7.70 | 1,300 | 10,010 | 1,355,194 | Dec 10, 2014, 09:13 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON DEVELOPMENT CORP ET AL | 10% Owner | Dec 05, 2014 | Sale | $7.78 | 4,200 | 32,676 | 1,363,494 | Dec 05, 2014, 06:57 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON DEVELOPMENT CORP ET AL | 10% Owner | Dec 03, 2014 | Sale | $7.75 | 1,627 | 12,609 | 1,377,767 | Dec 05, 2014, 06:57 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON DEVELOPMENT CORP ET AL | 10% Owner | Dec 04, 2014 | Sale | $7.76 | 10,073 | 78,166 | 1,367,694 | Dec 05, 2014, 06:57 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON DEVELOPMENT CORP ET AL | 10% Owner | Dec 01, 2014 | Sale | $7.54 | 1,200 | 9,048 | 1,379,394 | Dec 03, 2014, 02:24 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON DEVELOPMENT CORP ET AL | 10% Owner | Nov 25, 2014 | Sale | $7.80 | 1,500 | 11,700 | 1,381,094 | Nov 26, 2014, 04:18 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON DEVELOPMENT CORP ET AL | 10% Owner | Nov 26, 2014 | Sale | $7.60 | 500 | 3,800 | 1,380,594 | Nov 26, 2014, 04:18 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON | 10% Owner | Nov 20, 2014 | Sale | $8.21 | 3,100 | 25,451 | 1,388,994 | Nov 24, 2014, 05:45 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON DEVELOPMENT CORP ET AL | 10% Owner | Nov 21, 2014 | Sale | $8.25 | 2,400 | 19,800 | 1,386,594 | Nov 24, 2014, 05:45 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | JOHNSON & JOHNSON DEVELOPMENT CORP ET AL | 10% Owner | Nov 24, 2014 | Sale | $8.02 | 4,000 | 32,080 | 1,382,594 | Nov 24, 2014, 05:45 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | PFIZER INC | 10% Owner | Mar 12, 2014 | Buy | $11.00 | 272,727 | 2,999,997 | 1,235,330 | Mar 14, 2014, 03:27 PM | |
| AQXP | AQUINOX PHARMACEUTICALS, INC | Main David | President and CEO | Mar 12, 2014 | Option Exercise | $11.00 | 9,459 | 104,049 | 71,530 | Mar 14, 2014, 03:21 PM |
Menu